Atrial fibrillation (afib) before age 70 was tied to a 21 percent higher chance of cognitive impairment, a recent study found ...

Abbott’s pulse field ablation system competes with products from Medtronic and Boston Scientific, which also have large ...

Congress, Johnson & Johnson MedTech presented pivotal 12-month safety and effectiveness data from the SmartfIRE study—offering new insights into the future of atrial fibrillation (AFib) treatment. The ...

Abbott ABT recently announced CE Mark approval for the Volt Pulsed Field Ablation (“PFA”) system to treat patients battling atrial fibrillation (AFib). The development came earlier than expected, ...

Atrial fibrillation (or "AFib"), which causes an irregular heart rhythm, affects far fewer Americans—recent estimates put it ...

SmartfIRE 12-month data demonstrated 86.9% effectiveness when utilized with high adherence to the recommended ablation workflow and significant quality of life improvements using the Dual Energy ...

For patients with atrial fibrillation and obesity, lifestyle modification plus antiarrhythmic drug therapy conferred various ...

The SINGLE SHOT CHAMPION study increases momentum for PFA as a first-line option for pulmonary vein isolation, say experts.

The risk for new-onset or recurrent AF was not increased among older adult patients with preexisting conditions following RSV vaccination.

Discover how AFib before age 70 increases dementia risk by 21% and early-onset dementia risk by 36%. Learn prevention ...

Same-day discharge after joint replacement surgery is feasible in patients with a history of atrial fibrillation (AF), ...

Atrial fibrillation diagnosed in midlife is linked to a 21% increased risk of dementia at any age and a 36% higher risk of ...